Evidence map›Paper›PMID 29415440›Full record

ArticleToxins2018

Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping.

Carolina Alves Nicolau, Alyson Prorock, Yongde Bao, Ana Gisele da Costa Neves-Ferreira, Richard Hemmi Valente, Jay William Fox

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Carolina Alves NicolauLaboratory of Toxinology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, RJ 21040-900, Brazil. carolnicolau.bio@gmail.com.
Alyson ProrockDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA. ajp7x@virginia.edu.
Yongde BaoDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA. yb8d@virginia.edu.
Ana Gisele da Costa Neves-FerreiraLaboratory of Toxinology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, RJ 21040-900, Brazil. anag@ioc.fiocruz.br.
Richard Hemmi ValenteLaboratory of Toxinology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, RJ 21040-900, Brazil. richardhemmi@gmail.com.ORCID 0000-0002-6562-7571
Jay William FoxDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA. jwf8x@virginia.edu.
National Council for Scientific and Technological Development · BRUniversity of Virginia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Snake venoms are sources of molecules with proven and potential therapeutic applications. However, most activities assayed in venoms (or their components) are of hemorrhagic, hypotensive, edematogenic, neurotoxic or myotoxic natures. Thus, other relevant activities might remain unknown. Using functional genomics coupled to the connectivity map (C-map) approach, we undertook a wide range indirect search for biological activities within the venom of the South American pit viper

Indexed as

Drug DiscoveryAnimalsBothropsCrotalid VenomsHumansMCF-7 CellsTranscriptomeCrotalid Venomsbiosimilar drugsBothrops jararacaconnectivity mapdrug discoverytherapeutic potential

Identifiers

PMID29415440
PMCPMC5848170
OpenAlexW2791147800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.